Weak Induction of Interferon Expression by Severe Acute Respiratory Syndrome Coronavirus-2 Supports Clinical Trials of Interferon-λ to Treat Early Coronavirus Disease 2019

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisLederForskningpeer review

DOI

  • Thomas R. O'Brien, National Institutes of Health
  • ,
  • David L. Thomas, Johns Hopkins University
  • ,
  • Sarah S. Jackson, National Institutes of Health
  • ,
  • Ludmila Prokunina-Olsson, National Institutes of Health
  • ,
  • Raymond P. Donnelly, United States Food and Drug Administration
  • ,
  • Rune Hartmann
OriginalsprogEngelsk
TidsskriftClinical Infectious Diseases
Vol/bind71
Nummer6
Sider (fra-til)1410-12
Antal sider3
ISSN1058-4838
DOI
StatusUdgivet - 2020

Se relationer på Aarhus Universitet Citationsformater

ID: 188823899